Prothena:A Phase 3, Randomized, Multicenter, Double-Blind,Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosi
Clinical Trial Grant
Awarded By
Prothena Biosciences Limited
Start Date
February 24, 2022
End Date
February 28, 2027
Awarded By
Prothena Biosciences Limited
Start Date
February 24, 2022
End Date
February 28, 2027